Streetbeat News

Stock Prices

SPY

The USA Consumer Price Index (CPI) for September increased by 0.4%, beating the estimated 0.3% and higher than the previous month's 0.6%.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:30 pm

SPY

The Core CPI (MoM) for September has met the estimated value of 0.3%.

Portfolio Pulse from Bill Haddad

October 12, 2023 | 12:30 pm

FAST

Fastenal's shares are trading higher following the release of its mixed Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:26 pm

GFI

JP Morgan has upgraded Gold Fields from Underweight to Neutral and set a price target of $14. This has resulted in Gold Fields' shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:25 pm

ADBE

SJM

XLP

On CNBC's 'Halftime Report Final Trades', Liz Young of BNY Mellon Investment Management recommended Consumer Staples Select Sector SPDR Fund (XLP), Joseph Terranova of Virtus Investment Partners picked Adobe Inc. (ADBE), and Stephanie Link of Hightower chose The J. M. Smucker Company (SJM). BMO Capital Markets analyst reiterated the Outperform rating on Adobe with a price target of $645.00. J.M. Smucker is selling its Sahale Snacks brand to Second Nature Brands for around $34 million.

Portfolio Pulse from Lisa Levin

October 12, 2023 | 12:24 pm

HYLN

TGT

XOM

Several analyst forecasts were released on Thursday, with notable changes in price targets for various companies. Hyliion Holdings Corp. had its price target cut from $2 to $1 by Cantor Fitzgerald, while Target Corporation's price target was increased from $120 to $135 by B of A Securities. Exxon Mobil Corporation's price target was boosted from $110 to $131 by Truist Securities. Other companies with adjusted price targets include The Procter & Gamble Company, First Solar, Inc., Dynatrace, Inc., Kimberly-Clark Corporation, E2open Parent Holdings, Inc., Astria Therapeutics, Inc., ResMed Inc., and Keurig Dr Pepper Inc.

Portfolio Pulse from Lisa Levin

October 12, 2023 | 12:21 pm

OLPX

Olaplex Holdings, Inc. (NASDAQ:OLPX) announced a leadership transition with Amanda Baldwin set to become the new CEO by early 2024, succeeding JuE Wong. John P. 'JP' Bilbrey, the company's Executive Chair, will serve as interim CEO during the transition. The company reiterated its guidance for fiscal year 2023.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:19 pm

VSAT

Viasat, Inc. (NASDAQ:VSAT) has announced key financial developments that are expected to enhance its cash generation profile. The company now expects to reach sustainable positive free cash flow during the first half of 2025, earlier than previously announced. Viasat has also confirmed that it will not require a replacement for the ViaSat-3 F1 satellite, which encountered a mechanical deployment issue. The company expects to report more than $3 billion of liquidity as of September 30, 2023, and remains on track to achieve its outlook for FY2024.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:13 pm

DPZ

Domino's Pizza Inc (NYSE:DPZ) reported a Q3 FY23 sales decline of 3.9% YoY to $1.03 billion, missing the analyst consensus of $1.05 billion. The decrease was primarily due to lower supply chain and U.S. Company-owned store revenues. Global retail sales increased 4.9%, excluding the positive impact of foreign currency. The company had a global net store decrease of 8 stores. EPS of $4.18 beat the analyst consensus estimate of $3.30. The company's Board of Directors declared a $1.21 per share quarterly dividend. In Q3, the company repurchased and retired 229,860 shares of common stock for a total of $90 million.

Portfolio Pulse from Shivani Kumaresan

October 12, 2023 | 12:13 pm

INMD

InMode Ltd. (NASDAQ: INMD) has announced its Q3 2023 earnings per share (EPS) to be between $0.59-$0.60, lower than the estimated $0.66. The company also expects its 2023 revenue to be between $122.8M-$123.0M, lower than the estimated $136.94M. Furthermore, InMode has lowered its full-year 2023 revenue guidance to $500M-$510M from the original estimates of $530M-$540M. The company attributes these changes to factors such as economic slowdown, slower purchase decisions, and constraints in financing of medical equipment.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:12 pm